Tabo-tabo, Petra A.

HRN: 25-11-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
LEVOFLOXACIN 500MG (TAB)
07/09/2026
07/15/2026
ORAL
500mg
OD
Acute Lymphocytic Leukemia
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines